John Raslavsky

The controversy regarding prostate cancer screening can be overwhelming. Screening is the process by which one tries to identify a disease, such as prostate cancer, when someone is without symptoms. The goal is early detection, which may lead to improved survival. Screening for prostate cancer is accomplished using the PSA blood test and digital rectal

As discussed in last month?s blog, prostate cancer screening is controversial. How do you know if it?s right for you? The American Urological Association recommends that all men between the ages of 55 and 69 have a discussion with their doctor regarding the risks and benefits of prostate cancer screening, taking into account each man?s

If you are diagnosed with prostate cancer, there are multiple factors which determine your treatment options. These include your PSA level, whether or not abnormalities are felt on your prostate, the amount of prostate cancer present in your biopsy, and the Gleason score, which is a measure of the aggressiveness of the prostate cancer. Multiple

The physicians of ASUI have been treating men that are suffering from symptoms associated with Benign Prostatic Hyperplasia, or BPH. with the UroLift? System, a proven, minimally invasive technology, since 2016. The physicians state that: The UroLift? System preserves sexual function which is important to men and their partners. Patients like, that they can have

Using genomic sequencing, researchers have confirmed a link between a plant compound contained in common herbal remedies and upper urinary tract cancer. For their study, genomic sequencing experts at Johns Hopkins University, Baltimore partnered with pharmacologists at Stony Brook University, Stony Brook, NY to reveal a striking mutational signature of upper urinary tract cancers caused

The FDA is perceived and promoted as the guardian of public safety, but many are critical of the FDA approval and regulatory process for being either slow or broken. Some groups see the FDA as being too slow to approve new drugs or treatments that can extend for save lives, while others see the FDA